NEW YORK (GenomeWeb News) — The Broad Institute of MIT and Harvard will cut 24 employees from its Genome Sequencing Platform because new genomics technologies have made some staff unnecessary.

"The rapid evolution of DNA sequencing technologies has required the Broad Institute to transition its genome sequencing efforts from performing high-throughput work on the traditional technologies to actively developing and optimizing the use of next-generation high-throughput sequencing technologies," Broad said in an e-mail statement to reporters this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.